Cardiff Oncology
Divora Yemane is a Senior Research Associate at Cardiff Oncology since August 2021. Prior to that role, Divora worked as a Research Associate at Allele Biotechnology & Pharmaceuticals Inc. from June 2018 to August 2021. Divora holds a degree in Biochemistry and Cell Biology from UC San Diego, where Divora studied from 2015-2017, and an Associate's degree in Biology from San Diego Miramar College, where Divora attended from 2012-2015.
Cardiff Oncology
Cardiff Oncology is a clinical-stage biotechnology company with the singular mission of developing new treatment options for cancer patients in indications with the greatest medical need. Our goal is to overcome resistance, improve response to treatment and increase overall survival. We are developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.